Coverage at NY Times, front page today and my input to that piece To view or add a comment, sign in This week, a seven-person FDA advisory committee will spend two days deciding the fate of peptides my patients have been asking about for over a year
Retinol is known for stronger renewal-style effects, while copper peptides are often chosen for a gentler, supportive approach to firmness, smoothness and skin comfort
Presented for research literature review only Yano M et al
This is soon followed by a more significant visceral fat accumulation, one of the major risk factors for cardiovascular diseases
By targeting the FOXO4-p53 protein interaction responsible for keeping these damaged cells alive, FOXO4-DRI restores healthy cellular turnover, making it one of the most promising compounds in modern longevity and anti-aging research